首页> 美国卫生研究院文献>Journal of Antimicrobial Chemotherapy >Antimicrobial susceptibility and ribotypes of Clostridium difficile isolates from a Phase 2 clinical trial of ridinilazole (SMT19969) and vancomycin

【2h】

Antimicrobial susceptibility and ribotypes of Clostridium difficile isolates from a Phase 2 clinical trial of ridinilazole (SMT19969) and vancomycin

机译：ridinilazole（SMT19969）和万古霉素2期临床试验的艰难梭菌分离物的抗菌药敏性和核型

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
引文网络
相似文献
相关主题

摘要

ObjectivesWe evaluated the antimicrobial susceptibility and ribotypes of Clostridium difficile isolates from participants in a Phase 2 study of ridinilazole, a novel targeted-spectrum agent for treatment of C. difficile infection.

机译：目的我们在ridinilazole的第二阶段研究中评估了来自参与者艰难梭菌分离物的抗菌药敏性和核糖型，这是一种新型的靶向光谱剂，用于治疗艰难梭菌感染。

著录项

期刊名称 Journal of Antimicrobial Chemotherapy
作者
David R Snydman; Laura A McDermott; Cheleste M Thorpe; Justin Chang; Jenna Wick; Seth T Walk; Richard J Vickers;
展开▼
作者单位

展开▼
年(卷),期 -1(73),8
年度 -1
页码 2078–2084
总页数 7
原文格式 PDF
正文语种
中图分类药学;微生物学;病毒传染病;
关键词

相似文献

外文文献
中文文献
专利

1. Antimicrobial susceptibility and ribotypes of Clostridium difficile isolates from a Phase 2 clinical trial of ridinilazole (SMT19969) and vancomycin [J] . Snydman David R., McDermott Laura A., Thorpe Cheleste M., The Journal of Antimicrobial Chemotherapy . 2018,第8期

机译：来自啶唑（SMT19969）和万古霉素的2阶段临床试验的蛋白质腹菌分离株的抗菌易感性和核糖型
2. Nationwide surveillance of ribotypes and antimicrobial susceptibilities of toxigenic Clostridium difficile isolates with an emphasis on reduced doxycycline and tigecycline susceptibilities among ribotype 078 lineage isolates in Taiwan [J] . Yuan-Pin Hung, Pei-Jane Tsai, Yuan-Ti Lee, Infection and Drug Resistance . 2018,第7期

机译：全国产毒性梭状芽孢杆菌分离株的核型和耐药性监测，重点是台湾078核型分离株中强力霉素和替加环素的敏感性降低
3. Susceptibility of Clostridium difficile isolates from a Phase 2 clinical trial of cadazolid and vancomycin in C-difficile infection [J] . Gerding D. N., Hecht D. W., Louie T., The Journal of Antimicrobial Chemotherapy . 2016,第1期

机译：cadazolid和万古霉素2期临床试验中难辨梭状芽孢杆菌分离物在C难辨性感染中的敏感性
4. ANTIMICROBIAL SUSCEPTIBILITY OF CLOSTRIDIUM DIFFICILE ISOLATED FROM NEONATAL PIGS [C] . KW Post, JG Songer Congress of the International Pig Veterinary Society . 2002

机译：从新生猪中分离的梭菌差异的抗微生物易感性
5. Relationship between Clostridium difficile toxin type and clinical features, severity and outcome in patients with Clostridium difficile diarrhea (CDAD). [D] . Kachroo, Sumesh. 2008

机译：艰难梭菌腹泻（CDAD）患者的艰难梭菌毒素类型与临床特征，严重程度和预后之间的关系。
6. Susceptibility of Clostridium difficile isolates from a Phase 2 clinical trial of cadazolid and vancomycin in C. difficile infection [O] . D. N. Gerding, D. W. Hecht, T. Louie, -1

机译：cadazolid和万古霉素在艰难梭菌感染的2期临床试验中对艰难梭菌分离物的敏感性
7. Antimicrobial susceptibility and ribotypes of Clostridium difficile isolates from a Phase 2 clinical trial of ridinilazole (SMT19969) and vancomycin [O] . David R Snydman, Laura A McDermott, Cheleste M Thorpe, 2018

机译：来自啶唑（SMT19969）和万古霉素的2阶段临床试验的蛋白质腹菌分离物的抗菌剂易感性和核糖型
8. Evaluation and Research on Antimicrobial Stewardship's Effect on Clostridium difficile (ERASE C. difficile) Project. Toolkit for Reduction of Clostridium difficile through Antimicrobial Stewardship. [R] . 2012

机译：抗菌药物管理对艰难梭菌（ERasE C. difficile）项目影响的评价与研究。通过抗菌药物管理减少艰难梭菌的工具包。

Antimicrobial susceptibility and ribotypes of Clostridium difficile isolates from a Phase 2 clinical trial of ridinilazole (SMT19969) and vancomycin

摘要

著录项

引文网络

相似文献

相关主题

期刊订阅